132 related articles for article (PubMed ID: 11438176)
1. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Ramanathan M; Weinstock-Guttman B; Nguyen LT; Badgett D; Miller C; Patrick K; Brownscheidle C; Jacobs L
J Neuroimmunol; 2001 Jun; 116(2):213-9. PubMed ID: 11438176
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes.
Fischer HJ; Finck TLK; Pellkofer HL; Reichardt HM; Lühder F
Front Immunol; 2019; 10():1200. PubMed ID: 31191554
[TBL] [Abstract][Full Text] [Related]
3. Genomic effects of IFN-beta in multiple sclerosis patients.
Weinstock-Guttman B; Badgett D; Patrick K; Hartrich L; Santos R; Hall D; Baier M; Feichter J; Ramanathan M
J Immunol; 2003 Sep; 171(5):2694-702. PubMed ID: 12928423
[TBL] [Abstract][Full Text] [Related]
4. Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.
Rolla S; Bardina V; De Mercanti S; Quaglino P; De Palma R; Gned D; Brusa D; Durelli L; Novelli F; Clerico M
J Leukoc Biol; 2014 Dec; 96(6):1155-64. PubMed ID: 25097195
[TBL] [Abstract][Full Text] [Related]
5. Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.
Álvarez-Sánchez N; Cruz-Chamorro I; Díaz-Sánchez M; Lardone PJ; Guerrero JM; Carrillo-Vico A
Sci Rep; 2019 Feb; 9(1):2302. PubMed ID: 30783191
[TBL] [Abstract][Full Text] [Related]
6. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
[TBL] [Abstract][Full Text] [Related]
7. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood.
Edström M; Mellergård J; Mjösberg J; Jenmalm M; Vrethem M; Press R; Dahle C; Ernerudh J
Mult Scler; 2011 Jan; 17(1):57-66. PubMed ID: 20847001
[TBL] [Abstract][Full Text] [Related]
9. Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.
Achiron A; Gurevich M; Magalashvili D; Kishner I; Dolev M; Mandel M
Clin Dev Immunol; 2004; 11(3-4):299-305. PubMed ID: 15559377
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
[TBL] [Abstract][Full Text] [Related]
11. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
Farrokhi M; Saadatpour Z; Fadaee E; Saadatpour L; Rezaei A; Moeini P; Amani Beni A
Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):536-546. PubMed ID: 28129686
[TBL] [Abstract][Full Text] [Related]
12. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F
J Neuroinflammation; 2015 Jul; 12():132. PubMed ID: 26169064
[TBL] [Abstract][Full Text] [Related]
13. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.
Mandel M; Gurevich M; Pauzner R; Kaminski N; Achiron A
Clin Exp Immunol; 2004 Oct; 138(1):164-70. PubMed ID: 15373920
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.
Reder AT; Velichko S; Yamaguchi KD; Hamamcioglu K; Ku K; Beekman J; Wagner TC; Perez HD; Salamon H; Croze E
J Interferon Cytokine Res; 2008 May; 28(5):317-31. PubMed ID: 18547162
[TBL] [Abstract][Full Text] [Related]
16. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells.
Iglesias AH; Camelo S; Hwang D; Villanueva R; Stephanopoulos G; Dangond F
J Neuroimmunol; 2004 May; 150(1-2):163-77. PubMed ID: 15081262
[TBL] [Abstract][Full Text] [Related]
17. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis.
Sayad A; Omrani MD; Solgi G; Noroozi R; Arsang-Jang S; Inoko H; Taheri M
Iran J Allergy Asthma Immunol; 2017 Aug; 16(4):338-346. PubMed ID: 28865414
[TBL] [Abstract][Full Text] [Related]
19. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
